IL17A and COVID-19: Given the results above, as severe (stage IV) COVID-19 is outlined by increment of proinflammatory Th1 cytokines, IL-12 and IFN-γ, and Th17 cytokines, IL-17 and IL-23, we later on examined transcriptional activity of CD4+ and CD8+ T cells.